Consumer Brief Supporting NY Attorney General In Alzheimer's Drug Case

In December, a U.S. judge upheld the New York Attorney General's request for an injunction requiring the powerful Big Pharma company Actavis to continue marketing a lower-cost version of its Alzheimer's drug Namenda, instead of using a "product-hopping" scheme to move consumers to a newer but virtually identical version that would enjoy monopoly protection until 2029, making it unlikely that lower-cost generic alternatives could successfully enter the market. We joined other leading groups, including Consumers Union and Public Citizen, in a friend-of-the-court brief to the U.S. Second Circuit Court of Appeals supporting General Eric Schneiderman's defense against Actavis in its appeal. Our brief is attached.

Resource | Tax

U.S. PIRG Delivers 34,000 Petitions to D.O.J

Photo of Mario Salazar, U.S. PIRG legistlative director and Adam Weil, Environment America Federal Conservation Advocate, delivering 34,000 petitions calling for the Department of Justice to deny BP more tax deductions for its Gulf Coast oil spill settlements.

Resource | Tax

No Tax Write-Offs for Wall Street Wrongdoing

It is time the federal government stopped letting corporate wrongdoers add insult to injury by passing off the costs of their misconduct to taxpayers.


Subscribe to More Resources

Join Our Call

Tell your representative to stand up for our democracy, and amplify the voices of small donors in our elections.

Support Us

Your donation supports U.S. PIRG’s work to stand up for consumers on the issues that matter, especially when powerful interests are blocking progress.

Consumer Alerts

Join our network and stay up to date on our campaigns, get important consumer updates and take action on critical issues.
Optional Member Code